Fatigue Symptom Clinical Trial
Official title:
A Placebo-controlled, Randomized, Double-blind, Parallel, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of DA-5515 (Circulan® Soft Cap.) in Patients With Chronic Fatigue Symptoms Due to Impaired Blood Circulation
The aim of the present clinical study is to evaluate the efficacy and safety of the DA-5515 (Circulan Soft Cap.) in patients with chronic fatigue symptoms due to impaired blood circulation.
This study is conducting to assess the efficacy and safety of the DA-5515 (Circulan Soft Cap.), which has been known to have a fatigue recovery effect due to impaired blood circulation. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02645812 -
Validation of the French Version of the Fatigue Score "Brief Fatigue Inventory ( BFI)".
|
N/A |